Streetbeat News

Stock Prices

BCTX

BriaCell Therapeutics Corp. (NASDAQ:BCTX) has announced a $5 million registered direct offering of 2,402,935 common shares and warrants at a combined purchase price of $2 per share. The offering includes securities purchase agreements with healthcare-focused institutional investors and an existing investor and director of the company. The warrants have an exercise price of $2.11 per share and will become exercisable six months from issuance, expiring five years from the initial exercise date. The closing is expected around May 17, 2024, subject to customary conditions.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:16 pm

ARQT

BOLT

DLPN

FFIE

SINT

VRPX

Arcutis Biotherapeutics (NASDAQ:ARQT) shares surged 29% in pre-market trading after reporting better-than-expected Q1 earnings and sales. Other notable pre-market movers include Faraday Future Intelligent Electric (NASDAQ:FFIE), Sintx Technologies (NASDAQ:SINT), and Dolphin Entertainment (NASDAQ:DLPN) among gainers, while Virpax Pharmaceuticals (NASDAQ:VRPX) and Bolt Biotherapeutics (NASDAQ:BOLT) led the decliners.

Portfolio Pulse from Avi Kapoor

May 15, 2024 | 12:14 pm

JPM

MU

SLB

VMC

The Nasdaq 100 closed higher by more than 100 points on Tuesday. Notable insider trades were observed in Micron Technology, Vulcan Materials, Schlumberger, and JPMorgan Chase. Insider sales can indicate various factors, including preplanned sales or concerns about the company's prospects.

Portfolio Pulse from Avi Kapoor

May 15, 2024 | 12:14 pm

ALC

Alcon Inc. (NYSE:ALC) reported mixed Q1 results, beating earnings estimates but missing sales expectations. The company maintained its FY2024 guidance. Following the results, several analysts raised their price targets for Alcon. The stock gained 10.7% to close at $89.28.

Portfolio Pulse from Avi Kapoor

May 15, 2024 | 12:13 pm

RIVN

TLSA

Trading expert Anne-Marie Baiynd discussed Tesla Inc (NASDAQ:TLSA) option trades on Benzinga's YouTube, highlighting bullish strategies amid President Biden's increased tariffs on Chinese EVs. Rivian Motors (NASDAQ:RIVN) was also mentioned as a potential beneficiary.

Portfolio Pulse from Aaron Bry

May 15, 2024 | 12:11 pm

AAPL

GOOG

GOOGL

Alphabet Inc. (GOOG, GOOGL) showcased a new prototype of AR glasses at the Google I/O 2024 conference, hinting at a potential revival of Google Glass. This comes amid growing interest in AR technology, with competitors like Meta and Apple also making strides in the market.

Portfolio Pulse from Rounak Jain

May 15, 2024 | 12:11 pm

THRD

Third Harmonic Bio (NASDAQ:THRD) reported a Q1 2024 adjusted EPS of $(0.20), beating the analyst consensus estimate of $(0.31) by 35.48%.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:10 pm

TGL

Treasure Global (NASDAQ:TGL) reported Q3 EPS of $(2.32), beating the $(7.00) estimate, but sales of $1.60M missed the $16.34M estimate. EPS improved by 80.5% YoY, while sales decreased by 91.21% YoY.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 12:09 pm

SLDB

Solid Biosciences reported a Q1 net loss of $24.3 million, an improvement from the $30.1 million loss in the same quarter last year. The company ended the quarter with $206.1 million in cash and equivalents.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:59 am

DARE

Dare Bioscience shares are trading higher following an upgrade from Brookline Capital, which changed its rating from Hold to Buy and set a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

May 15, 2024 | 11:58 am